BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang XG, Revskaya E, Bryan RA, Strickler HD, Burk RD, Casadevall A, Dadachova E. Treating cancer as an infectious disease--viral antigens as novel targets for treatment and potential prevention of tumors of viral etiology. PLoS One 2007;2:e1114. [PMID: 17971877 DOI: 10.1371/journal.pone.0001114] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 López-urrutia E, Valdés J, Bonilla-moreno R, Martínez-salazar M, Martínez-garcia M, Berumen J, Villegas-sepúlveda N. A few nucleotide polymorphisms are sufficient to recruit nuclear factors differentially to the intron 1 of HPV-16 intratypic variants. Virus Research 2012;166:43-53. [DOI: 10.1016/j.virusres.2012.02.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
2 Helal M, Allen KJH, van Dijk B, Nosanchuk JD, Snead E, Dadachova E. Radioimmunotherapy of Blastomycosis in a Mouse Model With a (1→3)-β-Glucans Targeting Antibody. Front Microbiol 2020;11:147. [PMID: 32117166 DOI: 10.3389/fmicb.2020.00147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Bryan RA, Jiang Z, Jandl T, Strauss J, Koba W, Onyedika C, Morgenstern A, Bruchertseifer F, Epstein AL, Dadachova E. Treatment of experimental pancreatic cancer with 213-Bismuth-labeled chimeric antibody to single-strand DNA. Expert Rev Anticancer Ther 2014;14:1243-9. [PMID: 25156106 DOI: 10.1586/14737140.2014.952285] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
4 Obeid JM, Kunk PR, Zaydfudim VM, Bullock TN, Slingluff CL Jr. Rahma OE. Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time? Cancer Immunol Immunother. 2018;67:161-174. [PMID: 29052780 DOI: 10.1007/s00262-017-2082-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
5 [DOI: 10.1101/152264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Kim MK, Kim HS, Kim SH, Oh JM, Han JY, Lim JM, Juhnn YS, Song YS. Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment. Biochem Pharmacol 2010;80:1930-5. [PMID: 20643111 DOI: 10.1016/j.bcp.2010.07.013] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
7 Geller DS, Morris J, Revskaya E, Kahn M, Zhang W, Piperdi S, Park A, Koirala P, Guzik H, Hall C, Hoang B, Yang R, Roth M, Gill J, Gorlick R, Dadachova E. Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R). Nucl Med Biol 2016;43:812-7. [PMID: 27744117 DOI: 10.1016/j.nucmedbio.2016.07.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
8 Hammerbacher J, Snyder A. Informatics for cancer immunotherapy. Ann Oncol 2017;28:xii56-73. [PMID: 29253114 DOI: 10.1093/annonc/mdx682] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
9 Farmani AR, Mahdavinezhad F, Scagnolari C, Kouhestani M, Mohammadi S, Ai J, Shoormeij MH, Rezaei N. An overview on tumor treating fields (TTFields) technology as a new potential subsidiary biophysical treatment for COVID-19. Drug Deliv Transl Res 2021. [PMID: 34542840 DOI: 10.1007/s13346-021-01067-5] [Reference Citation Analysis]
10 Schlecht NF, Brandwein-Gensler M, Nuovo GJ, Li M, Dunne A, Kawachi N, Smith RV, Burk RD, Prystowsky MB. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer. Mod Pathol. 2011;24:1295-305. [PMID: 21572401 DOI: 10.1038/modpathol.2011.91] [Cited by in Crossref: 143] [Cited by in F6Publishing: 132] [Article Influence: 13.0] [Reference Citation Analysis]
11 Nosanchuk JD, Dadachova E. Radioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens. Front Microbiol 2011;2:283. [PMID: 22275913 DOI: 10.3389/fmicb.2011.00283] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
12 Beltrán Hernández I, Yu Y, Ossendorp F, Korbelik M, Oliveira S. Preclinical and Clinical Evidence of Immune Responses Triggered in Oncologic Photodynamic Therapy: Clinical Recommendations. J Clin Med 2020;9:E333. [PMID: 31991650 DOI: 10.3390/jcm9020333] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
13 Phaëton R, Gutierrez J, Jiang Z, Karabakhtsian RG, Albanese J, Sunkara J, Fisher DR, Goldberg GL, Dadachova E. Naive and radiolabeled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer. Immunotherapy 2015;7:631-40. [PMID: 26098137 DOI: 10.2217/imt.15.18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
14 Cao M, Xu Y, Youn JI, Cabrera R, Zhang X, Gabrilovich D, Nelson DR, Liu C. Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model. Lab Invest. 2011;91:598-608. [PMID: 21321535 DOI: 10.1038/labinvest.2010.205] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 7.2] [Reference Citation Analysis]
15 Anaya M, Gámez-Espinosa E, Valdés O, Guzmán T, Borrego S. Effect of the oscillating magnetic field on airborne fungal. Arch Microbiol 2021;203:2139-45. [PMID: 33611632 DOI: 10.1007/s00203-021-02193-x] [Reference Citation Analysis]
16 Dong Z, Hu R, Du Y, Tan L, Li L, Du J, Bai L, Ma Y, Cui H. Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers. Front Immunol 2020;11:586796. [PMID: 33488587 DOI: 10.3389/fimmu.2020.586796] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Harris M, Wang XG, Jiang Z, Goldberg GL, Casadevall A, Dadachova E. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line. Head Neck Oncol 2011;3:9. [PMID: 21314983 DOI: 10.1186/1758-3284-3-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
18 Pan RY, Chung WH, Chu MT, Chen SJ, Chen HC, Zheng L, Hung SI. Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens. J Immunol Res 2018;2018:4325874. [PMID: 30662919 DOI: 10.1155/2018/4325874] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
19 Phaeton R, Harris M, Jiang Z, Wang XG, Einstein MH, Goldberg GL, Casadevall A, Dadachova E. Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6. Cancer Biol Ther 2010;10:1041-7. [PMID: 20861673 DOI: 10.4161/cbt.10.10.13322] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
20 Sabatino D. Medicinal Chemistry and Methodological Advances in the Development of Peptide-Based Vaccines. J Med Chem 2020;63:14184-96. [PMID: 32990437 DOI: 10.1021/acs.jmedchem.0c00848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
21 Acebes-Fernández V, Landeria-Viñuela A, Juanes-Velasco P, Hernández AP, Otazo-Perez A, Manzano-Román R, Gongora R, Fuentes M. Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers. Nanomaterials (Basel) 2020;10:E1274. [PMID: 32610601 DOI: 10.3390/nano10071274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
22 Phaeton R, Jiang Z, Revskaya E, Fisher DR, Goldberg GL, Dadachova E. Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancer. Cancer Med 2016;5:9-16. [PMID: 26625938 DOI: 10.1002/cam4.562] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
23 Abraham TS, Snook AE. The swinging pendulum of cancer immunotherapy personalization. Personalized Medicine 2017;14:259-70. [DOI: 10.2217/pme-2016-0108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
24 Phaeton R, Wang XG, Einstein MH, Goldberg GL, Casadevall A, Dadachova E. The influence of proteasome inhibitor MG132, external radiation, and unlabeled antibody on the tumor uptake and biodistribution of (188)re-labeled anti-E6 C1P5 antibody in cervical cancer in mice. Cancer 2010;116:1067-74. [PMID: 20127955 DOI: 10.1002/cncr.24794] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
25 Harris M, Wang XG, Jiang Z, Phaeton R, Koba W, Goldberg GL, Casadevall A, Dadachova E. Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein. Br J Cancer 2013;108:859-65. [PMID: 23385729 DOI: 10.1038/bjc.2013.43] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
26 Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, Denner J, Miller K, Kurth R, Bannert N. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 2009;6:92. [PMID: 19835577 DOI: 10.1186/1742-4690-6-92] [Cited by in Crossref: 126] [Cited by in F6Publishing: 122] [Article Influence: 9.7] [Reference Citation Analysis]
27 Jiang Z, Albanese J, Kesterson J, Warrick J, Karabakhtsian R, Dadachova E, Phaëton R. Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer. Transl Oncol 2019;12:1289-95. [PMID: 31325765 DOI: 10.1016/j.tranon.2019.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]